Background and Objectives: Adverse health effects such as neurotoxic and carcinogenic effects through aluminum from cosmetic products have been repeatedly discussed. The dermal uptake and impact on the systemic aluminum load is still poorly understood. Therefore, we investigated the effect of daily antiperspirant use on the systemic aluminum load under real-life conditions. Methods: 21 healthy subjects meeting certain selection criteria to ensure a low systemic aluminum background load were asked to use a commercial aluminum-containing antiperspirant for 14 days. A questionnaire enquired about shaving habits and other sources of aluminum. Aluminum levels were measured before and after the exposure in 24-h urine and plasma using atomic absorption spectroscopy. Urine samples (n = 6) with <700 mg/day creatinine excretion or more than 30% difference in 24-h creatinine excretion were excluded from further analysis. Results: No significant increase in plasma aluminum concentration or total excreted aluminum per day before and after exposure was measurable. No sample exceeded the reference values of the general population (maximum: 9.42 µg/g creatinine and 2.1 µg/L plasma). Shaving habits did not have a significant influence on the systemic aluminum load. Also, no correlation between the total amount of antiperspirant applied and the systemic aluminum level could be demonstrated. Conclusions: No measurable contribution to the overall systemically available aluminum load due to daily use of an antiperspirant for 14 days could be shown, but real-life data concerning long-term use or higher concentrations are still lacking. Considering toxicological occupational exposure data, adverse neurotoxic changes are unlikely in the case of urinary excretion of <50 µg aluminum/g creatinine (= no observed adverse effect level), even following long-term exposure.

1.
European Commission
.
Directorate General for Health & Consumers. Opinion on the safety of aluminium in cosmetic products
.
Luxembourg
:
European Commission
;
2014
.
2.
Kraus
T
,
Schaller
KH
,
Angerer
J
,
Hilgers
RD
,
Letzel
S
.
Aluminosis—detection of an almost forgotten disease with HRCT
.
J Occup Med Toxicol
.
2006
Feb
;
1
(
1
):
4
.
[PubMed]
1745-6673
3.
Klotz
K
,
Weistenhöfer
W
,
Neff
F
,
Hartwig
A
,
van Thriel
C
,
Drexler
H
.
The Health Effects of Aluminum Exposure
.
Dtsch Arztebl Int
.
2017
Sep
;
114
(
39
):
653
9
.
[PubMed]
1866-0452
4.
Exley
C
.
Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer’s disease?
Mol Med Today
.
1998
Mar
;
4
(
3
):
107
9
.
[PubMed]
1357-4310
5.
Panel on Food Additives
.
Flavourings, Processing Aids and Food Contact Materials (AFC). Safety of aluminium from dietary intake - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Food Contact Materials (AFC)
.
EFSA J
.
2008
;
6
(
754
):
1
34
. 1831-4732
6.
Pineau
A
,
Guillard
O
,
Favreau
F
,
Marrauld
A
,
Fauconneau
B
,
Gaudin
A
, et al.
In vitro study of percutaneous absorption of aluminum from antiperspirants through human skin in the Franz™ diffusion cell
.
J Inorg Biochem
.
2012
May
;
110
:
21
6
.
[PubMed]
0162-0134
7.
Strassburger
J
,
Coble
DW
.
Infrared characterization of human sweat glands inhibited with aluminum chlorohydrate
.
J Cosmet Sci
.
1987
;
38
:
99
107
.1525-7886
8.
Hostynek
JJ
.
Factors determining percutaneous metal absorption
.
Food Chem Toxicol
.
2003
Mar
;
41
(
3
):
327
45
.
[PubMed]
0278-6915
9.
Flarend
R
,
Bin
T
,
Elmore
D
,
Hem
SL
.
A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26
.
Food Chem Toxicol
.
2001
Feb
;
39
(
2
):
163
8
.
[PubMed]
0278-6915
10.
de Ligt
R
,
van Duijn
E
,
Grossouw
D
,
Bosgra
S
,
Burggraaf
J
,
Windhorst
A
, et al.
Assessment of Dermal Absorption of Aluminum from a Representative Antiperspirant Formulation Using a 26 Al Microtracer Approach
.
Clin Transl Sci
.
2018
Nov
;
11
(
6
):
573
81
.
[PubMed]
1752-8054
11.
The German Federal Institute for Risk Assessment (BfR)
.
Aluminium-containing antiperspirants contribute to aluminium intake.
BfR Opin No 0072014
2014
:15.
12.
Priest
ND
.
The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update
.
J Environ Monit
.
2004
May
;
6
(
5
):
375
403
.
[PubMed]
1464-0325
13.
Fleischer
M
,
Schaller
KH
.
Determination in plasma by electrothermal atomic absoption spectrometry.
Anal Hazard Subst Biol Mater
1999
;Vol .6:47–61.
14.
Göen
T
,
Schaller
KH
,
Drexler
H
.
External quality assessment of human biomonitoring in the range of environmental exposure levels
.
Int J Hyg Environ Health
.
2012
Feb
;
215
(
2
):
229
32
.
[PubMed]
1438-4639
15.
Deutsche Forschungsgemeinschaft (DFG)
. List of MAK and BAT Values 2018. Maximum Concentrations and Biological Tolerance Values at the Workplace. Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Report 54. vol. 54. Weinheim: WILEY-VCH Verlag GmbH&Co. KGaA;
2018
.
16.
Minoia
C
,
Sabbioni
E
,
Apostoli
P
,
Pietra
R
,
Pozzoli
L
,
Gallorini
M
, et al.
Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects
.
Sci Total Environ
.
1990
Jun
;
95
:
89
105
.
[PubMed]
0048-9697
17.
Clark
NA
,
Teschke
K
,
Rideout
K
,
Copes
R
.
Trace element levels in adults from the west coast of Canada and associations with age, gender, diet, activities, and levels of other trace elements
.
Chemosphere
.
2007
Nov
;
70
(
1
):
155
64
.
[PubMed]
0045-6535
18.
Anane
R
,
Bonini
M
,
Grafeille
JM
,
Creppy
EE
.
Bioaccumulation of water soluble aluminium chloride in the hippocampus after transdermal uptake in mice
.
Arch Toxicol
.
1995
;
69
(
8
):
568
71
.
[PubMed]
0340-5761
19.
Gitelman
HJ
.
Aluminum exposure and excretion
.
Sci Total Environ
.
1995
Feb
;
163
(
1-3
):
129
35
.
[PubMed]
0048-9697
20.
Yokel
RA
,
McNamara
PJ
.
Aluminium toxicokinetics: an updated minireview
.
Pharmacol Toxicol
.
2001
Apr
;
88
(
4
):
159
67
.
[PubMed]
0901-9928
21.
Letzel
S
,
Drexler
H
,
Hartwig
A.
Addendum to Aluminium [BAT Value Documentation, 2009]. MAK-Collect. Occup. Health Saf., American Cancer Society;
2016
, p. 269–77. doi:.
22.
Bumberger
E
,
Vocke
M
. Aluminium in Deo-Produkten - Untersuchungsergebnisse
2013
. Bayer Landesamt Für Gesundh Leb 2013. https://www.lgl.bayern.de/produkte/kosmetika/kosmetische_mittel/ue_2013_deo_aluminium.htm#abschnitt_1 (accessed September 9, 2018).
23.
Redaktion Stiftung-Warentest
.
Risiko aus der Dose?
Produkttest Damen Deos und Antirtanspirantien. Stift-Warentest
;
2014
. pp.
30
5
.
24.
Redaktion Stiftung-Warentest
.
Sieben Sprays sind dufte
.
Produkttest Herren Deos und Antitranspirantien. Stift-Warentest
;
2016
. pp.
36
41
.
25.
Schlereth
T
,
Dieterich
M
,
Birklein
F
.
Hyperhidrosis—causes and treatment of enhanced sweating
.
Dtsch Arztebl Int
.
2009
Jan
;
106
(
3
):
32
7
.
[PubMed]
1866-0452
26.
Guillard
O
,
Fauconneau
B
,
Olichon
D
,
Dedieu
G
,
Deloncle
R
.
Hyperaluminemia in a woman using an aluminum-containing antiperspirant for 4 years
.
Am J Med
.
2004
Dec
;
117
(
12
):
956
9
.
[PubMed]
0002-9343
27.
Kiesswetter
E
,
Schäper
M
,
Buchta
M
,
Schaller
KH
,
Rossbach
B
,
Scherhag
H
, et al.
Longitudinal study on potential neurotoxic effects of aluminium: I. Assessment of exposure and neurobehavioural performance of Al welders in the train and truck construction industry over 4 years
.
Int Arch Occup Environ Health
.
2007
Oct
;
81
(
1
):
41
67
.
[PubMed]
0340-0131
28.
Kiesswetter
E
,
Schäper
M
,
Buchta
M
,
Schaller
KH
,
Rossbach
B
,
Kraus
T
, et al.
Longitudinal study on potential neurotoxic effects of aluminium: II. Assessment of exposure and neurobehavioral performance of Al welders in the automobile industry over 4 years
.
Int Arch Occup Environ Health
.
2009
Nov
;
82
(
10
):
1191
210
.
[PubMed]
0340-0131
29.
Bielarczyk
H
,
Tomaszewicz
M
,
Szutowicz
A
.
Effect of aluminum on acetyl-CoA and acetylcholine metabolism in nerve terminals
.
J Neurochem
.
1998
Mar
;
70
(
3
):
1175
81
.
[PubMed]
0022-3042
30.
Nday
CM
,
Drever
BD
,
Salifoglou
T
,
Platt
B
.
Aluminium interferes with hippocampal calcium signaling in a species-specific manner
.
J Inorg Biochem
.
2010
Sep
;
104
(
9
):
919
27
.
[PubMed]
0162-0134
31.
Parkinson
IS
,
Ward
MK
,
Kerr
DN
.
Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis
.
J Clin Pathol
.
1981
Nov
;
34
(
11
):
1285
94
.
[PubMed]
0021-9746
32.
Klotz
K
,
Meyer‐Baron
M
,
van Thriel
C
,
Pallapies
D
,
Nasterlack
M
,
Letzel
S
, et al.
Addendum zu Aluminium [BAT Value Documentation in German language, 2018]. MAK-Collect. Occup. Health Saf., American Cancer Society;
2018
, p. 2054–88. doi:.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.